Abstract | BACKGROUND: RESULTS: Here we show that over-expression of Mcl-1 in pancreatic patient tumor samples is linked to advancement of the disease. We have previously shown that triptolide, a diterpene triepoxide, is effective both in vitro and in vivo, in killing pancreatic cancer cells. Decrease of Mcl-1 levels, either by siRNA or by treatment with triptolide results in cell death. Using pancreatic cancer cell lines, we have shown that miR-204, a putative regulator of Mcl-1, is repressed in cancer cell lines compared to normal cells. Over-expression of miR-204, either by a miR-204 mimic, or by triptolide treatment results in a decrease in Mcl-1 levels, and a subsequent decrease in cell viability. Using luciferase reporter assays, we confirmed the ability of miR-204 to down-regulate Mcl-1 by directly binding to the Mcl-1 3' UTR. Using human xenograft samples treated with Minnelide, a water soluble variant of triptolide, we have shown that miR-204 is up-regulated and Mcl-1 is down-regulated in treated vs. control tumors. CONCLUSION:
|
Authors | Zhiyu Chen, Veena Sangwan, Sulagna Banerjee, Tiffany Mackenzie, Vikas Dudeja, Xiaowu Li, Huaizhi Wang, Selwyn M Vickers, Ashok K Saluja |
Journal | Molecular cancer
(Mol Cancer)
Vol. 12
Issue 1
Pg. 105
(Sep 11 2013)
ISSN: 1476-4598 [Electronic] England |
PMID | 24025188
(Publication Type: Journal Article)
|
Chemical References |
- 3' Untranslated Regions
- Antineoplastic Agents
- Diterpenes
- Epoxy Compounds
- MCL1 protein, human
- MIRN204 microRNA, human
- MicroRNAs
- Myeloid Cell Leukemia Sequence 1 Protein
- Organophosphates
- Phenanthrenes
- triptolide
- 14-O-phosphonooxymethyltriptolide disodium salt
|
Topics |
- 3' Untranslated Regions
- Animals
- Antineoplastic Agents
(pharmacology)
- Base Sequence
- Binding Sites
- Cell Death
- Cell Line, Tumor
- Diterpenes
(pharmacology)
- Epithelium
(metabolism)
- Epoxy Compounds
(pharmacology)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Liver Neoplasms
(drug therapy, metabolism, secondary)
- Mice
- Mice, SCID
- MicroRNAs
(physiology)
- Myeloid Cell Leukemia Sequence 1 Protein
(genetics, metabolism)
- Organophosphates
(pharmacology)
- Pancreatic Ducts
(metabolism, pathology)
- Pancreatic Neoplasms
(drug therapy, metabolism, pathology)
- Phenanthrenes
(pharmacology)
- RNA Interference
- Up-Regulation
- Xenograft Model Antitumor Assays
|